Biomedical Investment Fund

R&D Tax Incentive

R&D Tax incentive: How Australia is making clinical trials cost competitive:

The R&D Tax Incentive is the Australian Government’s principal measure to encourage industry investment in research and development. It is a broad-based, market driven program that aims to boost company competitiveness, improve productivity and deliver economy-wide benefits to Australia.

The R&D Tax Incentive replaces the R&D Tax Concession from 1 July 2011 and is jointly administered by AusIndustry (on behalf of Innovation Australia) and the Australian Taxation Office (ATO).

Planning to run a clinical trial in Australia?

43.5% “cash back” benefit now available for eligible foreign companies undertaking R&D in Australia.

To learn more about why you are entering the international market from Australia, please schedule an appointment with us.



Special Go
AMEC - Spring Information Day 2023